Your browser doesn't support javascript.
loading
Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study.
Drogan, Dagmar; Dunn, Warwick B; Lin, Wanchang; Buijsse, Brian; Schulze, Matthias B; Langenberg, Claudia; Brown, Marie; Floegel, Anna; Dietrich, Stefan; Rolandsson, Olov; Wedge, David C; Goodacre, Royston; Forouhi, Nita G; Sharp, Stephen J; Spranger, Joachim; Wareham, Nick J; Boeing, Heiner.
Afiliação
  • Drogan D; Department of Epidemiology and drogan@dife.de.
  • Dunn WB; Centre for Endocrinology and Diabetes, Institute of Human Development, and Centre for Advanced Discovery and Experimental Therapeutics (CADET), Central Manchester University Hospitals National Health Service Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK; School of Chem
  • Lin W; Centre for Endocrinology and Diabetes, Institute of Human Development, and Centre for Advanced Discovery and Experimental Therapeutics (CADET), Central Manchester University Hospitals National Health Service Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK; School of Chem
  • Buijsse B; Department of Epidemiology and.
  • Schulze MB; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany;
  • Langenberg C; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, UK;
  • Brown M; Centre for Endocrinology and Diabetes, Institute of Human Development, and Centre for Advanced Discovery and Experimental Therapeutics (CADET), Central Manchester University Hospitals National Health Service Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK; School of Chem
  • Floegel A; Department of Epidemiology and.
  • Dietrich S; Department of Epidemiology and.
  • Rolandsson O; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden;
  • Wedge DC; School of Chemistry and Manchester Centre for Integrative Systems Biology, University of Manchester, Manchester, UK; Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK;
  • Goodacre R; School of Chemistry and Manchester Centre for Integrative Systems Biology, University of Manchester, Manchester, UK;
  • Forouhi NG; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, UK;
  • Sharp SJ; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, UK;
  • Spranger J; Department of Endocrinology, Diabetes and Nutrition, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Wareham NJ; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, UK;
  • Boeing H; Department of Epidemiology and.
Clin Chem ; 61(3): 487-97, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25524438
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article